SECUREKLOUD TECHNOLOGIES LIMITED announced on May 27, 2025, that its step-down subsidiary, QuantumNexis Inc., will acquire Niyama Healthcare Inc. and Ezovion Solutions Private Limited. This strategic move aims to launch QuantumNexis as a new subsidiary focused on AI-powered SaaS solutions for the global healthcare market, serving as an innovation engine for recurring revenue business lines.
-
Acquisition Details:
- Target Entities:
- Niyama Healthcare Inc.: A US-based pioneer in AI-driven digital mental wellness, incorporated on June 30, 2022. It delivers a fully digital, evidence-based mental wellness platform with a proprietary Generative AI engine for personalized treatment.
- Ezovion Solutions Private Limited: An India-incorporated leading provider of cloud-based AI-powered hospital information systems (HIS), incorporated on July 27, 2018. It offers a modular HIS connecting care workflows across diagnostics, medications, EHR, and revenue cycle management, deployed in over 325 hospitals across Asia and MEA.
- Objects and Impact: The integration of Niyama’s personalized Gen AI mental health technology with Ezovion’s hospital intelligence platform is expected to address urgent global demands in clinical efficiency, mental health accessibility, and healthcare automation. This also aims to unlock significant valuation upside by isolating the fastest-growing business into QuantumNexis.
- Consideration: Upfront cash, stock, and performance-based earn-out.
- Cost of Acquisition: USD 5,700,000.
- Shareholding Acquired: 100% of Niyama Healthcare Inc.'s assets and 76% of Ezovion Solutions Private Limited's equity.
- Ezovion Solutions Private Limited Revenue:
- FY23: ₹1.12 crore
- FY24: ₹1.91 crore
- FY25: ₹2.53 crore
- Completion Time: Indicative time for completion is 90 days.
- Approvals: No governmental or regulatory approvals are required.
- Related Party Transaction: The acquisition does not fall under related party transactions.
-
Management Commentary:
- Sujatha Ramesh, Chief Operating Officer of Healthcare Triangle, Inc. (HCTI), stated, "QuantumNexis marks a pivotal step in our growth strategy by separating our Gen AI SaaS innovation from traditional services. With Niyama and Ezovion, we’re launching an intelligent, global healthcare platform that delivers measurable impact at scale."
- David Ayanoglou, Chief Financial Officer of HCTI, added, "This structure unlocks significant valuation upside. By isolating our fastest-growing business into QuantumNexis, we are improving transparency, enhancing capital strategy, and positioning HCTI for long-term shareholder value creation."